Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Krukenberg Tumor × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 74 Breast Neoplasms 52 Neoplasms 31 Lung Neoplasms 30 Prostatic Neoplasms 29 Multiple Myeloma 29 Neoplasm Metastasis 22 Leukemia, Lymphocytic, Chronic, B-Cell 19 Ovarian Neoplasms 16 Colorectal Neoplasms 16 Recurrence 14 Lymphoma, Large B-Cell, Diffuse 14 Urinary Bladder Neoplasms 13 Squamous Cell Carcinoma of Head and Neck 13 Parkinson Disease 4, Autosomal Dominant Lewy Body 13 Leukemia, Myeloid, Acute 12 Carcinoma, Renal Cell 12 Small Cell Lung Carcinoma 11 Myasthenia Gravis 11 Triple Negative Breast Neoplasms 10 Endometrial Neoplasms 10 Pancreatic Neoplasms 9 Head and Neck Neoplasms 9 Carcinoma, Hepatocellular 9 Carcinoma 9 Brain Neoplasms 9 Melanoma 8 Stomach Neoplasms 7 Hematologic Neoplasms 7 Glioblastoma 7

Interventions

Laparotomy 1 Hyperthermic Intraperitoneal Chemotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01226394 2026-04-06

ProphyloCHIP

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed

Krukenberg Tumor, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡